Where is the global innovation and the opportunity in CGTs?

This is the latest episode of the free DDW narrated podcast, titled “How to utilise clinical trials in drug discovery” which covers five articles written for Volume 24 – Issue 1, Winter 2022/2023 of DDW.

They are called:

• The promise and growth of cell and gene therapies
• No sign of stopping: The rise of cell and gene therapy
• Expert view: What's next for cell and gene therapy?
• Understanding the future roadmaps of cell and gene therapy
• Under the microscope: Zoning in on the CGT sector

In the first article, DDW's Megan Thomas comments on the state of the CGT industry.

In the second, Ryan Leahy, a science communication expert in cell and gene therapy, at Phacilitate, says there is a lot to celebrate but also much to assess, question and challenge in this sector.

In the third, DDW's Megan Thomas explores the global innovations in cell and gene therapy and what opportunities and challenges are emerging and can therapies get to market faster.

In the fourth, DDW's Megan Thomas caught up with George White, General Manager, Product Management, Cell & Gene Therapy at Cytiva, to learn more about the company’s insight into the CGT market.

In the fifth and final article, IB Communications’ CEO Michelle Boxall explains why there are two sides to the cell and gene therapy coin.